Z-2086-2021 Class II Terminated

Recalled by Fresenius Medical Care Holdings, Inc. — Waltham, MA

FDA device recall Z-2086-2021 was initiated by Fresenius Medical Care Holdings, Inc. on Apr 28, 2021 and is designated Class II. Reason for recall: Exposed to freezing temperatures due to refrigerated truck malfunctions The recall status is terminated (terminated Aug 8, 2022). Affected quantity: (1) 1 case (2) 4 cases (3) 5 cases.

Recall details

Product Type
Devices
Report Date
Jul 28, 2021
Initiation Date
Apr 28, 2021
Termination Date
Aug 8, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
(1) 1 case (2) 4 cases (3) 5 cases

Product description

Citrasate Liquid Acid Concentrate and NaturaLyte Liquid Acid Concentrate are each intended to be used as one component in the preparation of dialysate in a 3-stream proportioning hemodialysis machine according to a physician s prescription. Both concentrates are formulated for use in 45X proportioning systems which proportion a nominal ratio of 1 : 1.72 : 42.28 (acid : bicarbonate : water) to generate dialysate. The dialysate is intended to be pumped through a dialyzer, creating an osmotic gradient across the dialyzer membrane to exchange solutes with blood during hemodialysis.

Reason for recall

Exposed to freezing temperatures due to refrigerated truck malfunctions

Distribution pattern

US Distribution to: TX only

Code information

Lot Number/UDI: (1)21BTAC004 UDI: (01)00840861101535 (2)21AGAC026 UDI: (01)00840861101696 (3)21BTAC008 UDI: (01)00840861101740

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2086-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-2086-2021. Report a data issue: hello@regdatalab.com.